Coverage dated October 20, 2022 to October 21, 2022
Pfizer says Covid-19 vaccine list price could be $130 per dose once government contracts end
Headline from Local News 8
By Deidre McPhillips and Amanda Sealy, CNN Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its Covid-19 vaccine will be sold for $110 to $130 per dose.
Local News 8's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The drugmaker said it expects that people with private health insurance or coverage through public programs like Medicare or Medicaid will pay nothing.
Pfizer said the commercial pricing for adult COVID-19 vaccine doses could start in early 2023, depending on when the U.S. government phases out its program of buying the shots.
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free.
Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.
By Deidre McPhillips and Amanda Sealy, CNN Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its Covid-19 vaccine will be sold for $110 to $130 per dose.
Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Pfizer says Covid-19 vaccine list price could be $130 per dose once government contracts end | Since Then
